The Listing Committee acts both as an independent administrative decision maker and an advisory body for the Exchange. It has four principal functions:
- to oversee the Division (to the extent practicable given the Committee’s mode of operation);
- to provide policy advice to the Division on listing matters and to approve amendments to the Main Board Rules and GEM Rules;
- to take decisions of material significance for listing applicants, listed issuers and the individuals concerned. These include approvals of listing applications and cancellations of listing and disciplinary matters; and
- to act as a review body for decisions made by the Division.
Role and Mode of Operation of the Committee
CHAIRMAN
BHATIA Renu
|
Age
|
65
|
|
Date of appointment
|
5 July 2019
|
|
Other major offices
|
- Opharmic Technologies Ltd – Chairman and Co-Founder (2015~)
- Asia Fintech Angels – Co-founder (2015~)
- Garsington Technologies – Advisor to the Board (2016~)
- Overstone Associates Limited – Board Member (2022~)
- Bite Investments – Advisor to the Board (2022~)
- HUTCHMED (China) Limited – Independent Non-Executive Director (2024~)
|
|
Past offices
|
- Supercharger – Founding Partner (2015 – 2021)
- Prospect Ventures – President (2013 – 2017)
- Tancho Investments Ltd – Director (2005 – 2015)
- HSBC Asset Management – Director Head of Tactical Asset Allocation (1992 – 1999)
- Goldman Sachs – Associate – Investment banking (1988 – 1991)
|
|
Public service
|
- Innovation and Technology Commission – Enterprise Support Scheme Assessor (2021~)
- Cyberport Entrepreneurship Centre Advisory Group – Member (2018~)
- Business Professional Federation Healthcare Committee – Member (2016~)
|
|
Qualifications
|
- Master of Business Administration (Yale University)
- Doctor of Medicine (University of London)
- Post Grad Diploma in Therapeutics and Medicine (The University of Hong Kong)
|